Sumitomo Mitsui Trust Group
BNTX icon

Sumitomo Mitsui Trust Group’s BioNTech BNTX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3M Sell
32,214
-45,480
-59% -$4.28M ﹤0.01% 775
2026
Q1 		$6.91M Buy
+77,694
New +$7.98M ﹤0.01% 697

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Sumitomo Mitsui Trust Group's BNTX Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its BioNTech (BNTX) stake by 59% in Q2 2026, selling an estimated $4.28M and leaving 32,214 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #775.

Sumitomo Mitsui Trust Group first reported a position in BNTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.91M in Q1 2026. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 32,214 shares of BioNTech worth $3M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 45,480 BioNTech shares in Q2 2026, an estimated $4.28M.
  • BioNTech made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #775 holding.
  • Sumitomo Mitsui Trust Group first reported a position in BioNTech in Q1 2026 and has held it in 2 quarters since.
  • Sumitomo Mitsui Trust Group's BioNTech position peaked at $6.91M in Q1 2026.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.